FL
BIO icon

Fort LP’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fort LP’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-588
Closed -$444K – 271
2021
Q4 		$444K Sell
588
-672
-53% -$503K 0.14% 235
2021
Q3 		$940K Sell
1,260
-662
-34% -$496K 0.31% 156
2021
Q2 		$1.24M Sell
1,922
-719
-27% -$438K 0.36% 159
2021
Q1 		$1.51M Buy
2,641
+350
+15% +$207K 0.42% 158
2020
Q4 		$1.34M Buy
2,291
+1,269
+124% +$723K 0.4% 163
2020
Q3 		$527K Buy
+1,022
New +$518K 0.22% 202
2019
Q4 		– Sell
-362
Closed -$120K – 449
2019
Q3 		$120K Buy
+362
New +$118K 0.02% 325

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fort LP's BIO Position: Q1 2022 in Review

Fort LP sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2022, closing a stake of 588 shares — an estimated $444K sold.

Fort LP first reported a position in BIO in Q3 2019 and held it in 7 quarters. The position peaked at $1.51M in Q1 2021. 514 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

  • Fort LP reported no remaining Bio-Rad Laboratories Class A position as of Q1 2022 after selling out during the quarter.
  • Fort LP sold 588 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $444K.
  • Fort LP first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 7 quarters.
  • Fort LP's Bio-Rad Laboratories Class A position peaked at $1.51M in Q1 2021.
  • 514 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on Fort LP's 13F filing for Q1 2022, filed 13 May 2022.